title: The quality of registration of clinical trials.
abstract: BACKGROUND
  Lack of transparency in clinical trial conduct, publication bias and selective reporting bias are still important problems in medical research. Through clinical trials registration, it should be possible to take steps towards resolving some of these problems. However, previous evaluations of registered records of clinical trials have shown that registered information is often incomplete and non-meaningful. If these studies are accurate, this negates the possible benefits of registration of clinical trials.
  
  
  RESULTS
  A 5% sample of records of clinical trials that were registered between 17 June 2008 and 17 June 2009 was taken from the International Clinical Trials Registry Platform (ICTRP) database and assessed for the presence of contact information, the presence of intervention specifics in drug trials and the quality of primary and secondary outcome reporting. 731 records were included. More than half of the records were registered after recruitment of the first participant. The name of a contact person was available in 94.4% of records from non-industry funded trials and 53.7% of records from industry funded trials. Either an email address or a phone number was present in 76.5% of non-industry funded trial records and in 56.5% of industry funded trial records. Although a drug name or company serial number was almost always provided, other drug intervention specifics were often omitted from registration. Of 3643 reported outcomes, 34.9% were specific measures with a meaningful time frame.
  
  
  CONCLUSIONS
  Clinical trials registration has the potential to contribute substantially to improving clinical trial transparency and reducing publication bias and selective reporting. These potential benefits are currently undermined by deficiencies in the provision of information in key areas of registered records.
authors.affiliation: Department of Research Policy and Cooperation (RPC), International Clinical Trials Registry Platform (ICTRP), World Health Organization (WHO), Geneva, Switzerland.
authors.forename: Roderik F
authors.initials: RF
authors.lastname: Viergever
authors.forename: Davina
authors.initials: D
authors.lastname: Ghersi
mesh_terms: D000465:Algorithms; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards* / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D017594:Publication Bias; D011643:Publishing / Q000592:standards; D011786:Quality Control; D011996:Records / Q000592:standards; D012042:Registries; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome